Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-20

Clinical Trial Update: Effect of Olopatadine on Allergic Tear Mediators [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of olopatadine on tear mediators in allergic conjunctivitis; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE (OLOPATADINE)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Allergic Conjunctivitis | NA | Status: COMPLETED | Results posted: 2018-09-20